The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility. Issue 3 (21st June 2018)

• Record Type: Journal Article
• Authors: Zhao, Zhiguang; Zhang, Anqi; Zhao, Yuan; Xiang, Junmiao; Yu, Danyang; Liang, Zongwen; Xu, Chaoyi; Zhang, Qiong; Li, Jianmin; Duan, Ping
• Is Part Of: Bioscience reports. Volume 38:Issue 3(2018)
• Publication Date: 2018-06-21
• Subjects: case-control study -- genetic susceptibility -- nucleotide excision repair -- ovarian cancer -- polymorphism; Molecular biology -- Periodicals; Cytology -- Periodicals; 572.8
• DOI: 10.1042/BSR20180114
• Languages: English
• ISSNs: 0144-8463

Abstract

Abstract : Nucleotide excision repair (NER), the core mechanism of DNA repair pathway, was commonly used to maintain genomic stability and prevent tumorigenesis. Previous investigations have demonstrated that single nucleotide polymorphisms (SNPs) of NER pathway genes were associated with various types of cancer. However, there was no research elucidating the genetic association of entire NER pathway with ovarian cancer susceptibility. Therefore, we conducted genotyping for 17 SNPs of six NER core genes ( XPA, XPC, XPG, ERCC1, ERCC2, and ERCC4 ) in 89 ovarian cancer cases and 356 cancer-free controls. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to describe the strength of association. The result showed that both ERCC1 rs11615 and XPC rs2228000 were significantly associated with reduced risk of ovarian cancer under dominant genetic model (adjusted OR = 0.35, 95% CI = 0.20–0.61, P =0.0002 and adjusted OR = 0.49, 95% CI = 0.30–0.81, P =0.005 respectively). In addition, XPC rs2228001 and ERCC2 rs238406 had statistically significant association with the increased risk of ovarian cancer under dominant genetic model (adjusted OR = 1.72, 95% CI = 1.02–2.92, P =0.043 and adjusted OR = 2.07, 95% CI = 1.07–4.01, P =0.032 respectively). ERCC1 rs3212986 were related with the increased risk of ovarian cancer under recessive model (adjusted OR = 2.40, 95% CI = 1.30–4.44, P =0.005). In conclusion, our results indicated that ERCC1, XPC and ERCC2 might influence ovarian cancer susceptibility. Further research with large sample size is warranted to validate the reliability and accuracy of our results.